Review



mutation-specific ihc ve1 antibody  (Spring Bioscience)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Spring Bioscience mutation-specific ihc ve1 antibody
    Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by <t>IHC</t> (BRAFIHC) and NGS (BRAFNGS).
    Mutation Specific Ihc Ve1 Antibody, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mutation-specific ihc ve1 antibody/product/Spring Bioscience
    Average 90 stars, based on 1 article reviews
    mutation-specific ihc ve1 antibody - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Population-based screening for BRAF V600E in metastatic colorectal cancer reveals increased prevalence and poor prognosis"

    Article Title: Population-based screening for BRAF V600E in metastatic colorectal cancer reveals increased prevalence and poor prognosis

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    doi: 10.1158/1078-0432.CCR-20-1024

    Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by IHC (BRAFIHC) and NGS (BRAFNGS).
    Figure Legend Snippet: Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by IHC (BRAFIHC) and NGS (BRAFNGS).

    Techniques Used:

    Multivariate analysis of impact of patient characteristics on overall survival of metastatic colorectal cancer patients.
    Figure Legend Snippet: Multivariate analysis of impact of patient characteristics on overall survival of metastatic colorectal cancer patients.

    Techniques Used:



    Similar Products

    mutation-specific ihc ve1 antibody  (Spring Bioscience)
    90
    Spring Bioscience mutation-specific ihc ve1 antibody
    Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by <t>IHC</t> (BRAFIHC) and NGS (BRAFNGS).
    Mutation Specific Ihc Ve1 Antibody, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mutation-specific ihc ve1 antibody/product/Spring Bioscience
    Average 90 stars, based on 1 article reviews
    mutation-specific ihc ve1 antibody - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by IHC (BRAFIHC) and NGS (BRAFNGS).

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Population-based screening for BRAF V600E in metastatic colorectal cancer reveals increased prevalence and poor prognosis

    doi: 10.1158/1078-0432.CCR-20-1024

    Figure Lengend Snippet: Kaplan-Meier estimation of overall survival of patients with mCRC and BRAFV600E mutations detected by IHC (BRAFIHC) and NGS (BRAFNGS).

    Article Snippet: BRAF Immunohistochemistry: Within VCH, BRAF V600E mutation status was determined by mutation-specific IHC (VE1 antibody, Spring Bioscience) with on-slide control as previously described 9 .

    Techniques:

    Multivariate analysis of impact of patient characteristics on overall survival of metastatic colorectal cancer patients.

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Population-based screening for BRAF V600E in metastatic colorectal cancer reveals increased prevalence and poor prognosis

    doi: 10.1158/1078-0432.CCR-20-1024

    Figure Lengend Snippet: Multivariate analysis of impact of patient characteristics on overall survival of metastatic colorectal cancer patients.

    Article Snippet: BRAF Immunohistochemistry: Within VCH, BRAF V600E mutation status was determined by mutation-specific IHC (VE1 antibody, Spring Bioscience) with on-slide control as previously described 9 .

    Techniques: